2025 annual financial data
NewAmsterdam Pharma 2025 Operating margin
Direct answer
Operating margin was -1,002.9%.
Operating income was -225,683,000 USD and net income was -203,819,000 USD.
Operating cash flow was -147,783,000 USD.
Get free NewAmsterdam Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 22,503,000 USD
- Operating income
- -225,683,000 USD
- Net income
- -203,819,000 USD
- Operating cash flow
- -147,783,000 USD